Apexigen, Inc.
NASDAQ: APGN0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Xiaodong Yang
- Employees
- 11
- Headquarters
- San Carlos, United States
- IPO year
- 2021
- Market cap
- $9.6M
- Website
- https://www.apexigen.com
Loading APGN…
Loading profile data…Frequently asked questions about APGN
What does Apexigen, Inc. (APGN) do?
Apexigen Inc., established in 2010 and based in San Carlos, California, is a clinical-stage biotechnology company dedicated to the discovery and advancement of antibody-based therapies for oncological diseases. The company's developmental pipeline features several promising candidates. A primary focus is APX005M, a humanized agonist antibody cur...
Where does APGN trade?
Apexigen, Inc. (APGN) trades on the NASDAQ Capital Market.
What sector is APGN in?
Apexigen, Inc. (APGN) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Apexigen, Inc.?
Xiaodong Yang is the chief executive officer of Apexigen, Inc. (APGN).
Where is Apexigen, Inc. headquartered?
Apexigen, Inc. is headquartered in United States.
Does APGN pay a dividend?
Apexigen, Inc. (APGN) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did APGN go public?
Apexigen, Inc. (APGN) completed its initial public offering in 2021.